Anti-CD38 mAbs eliminate multiple myeloma targets by mediating CDC, ADCC, ADCP, FCγR-mediated cross-linking–induced apoptosis and nicotinamide adenine dinucleotide (NAD+) depletion [132]. Here, CD38 is linked to AL amyloidosis.